These data are in concordance with recent findings in which the expression and the activity of S1P2 are associated with increased BBB permeability and more severe signs in experimental autoimmune encephalomyelitis (EAE), an animal model of neuroinflammation in MS [37]. Here, S1PR2 is linked to myeloid sarcoma.